Immune Surveillance of the CNS following Infection and Injury

Trends in Immunology

Volumn 36, Issue 10, 2015, Pages 637-650

  Russo, Matthew V ^a   McGavern, Dorian B ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INFECTION; INJURY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; REVIEW; ANIMAL; CENTRAL NERVOUS SYSTEM INFECTION; CYTOLOGY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; NERVOUS SYSTEM INJURY; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; WOUND HEALING;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTIONS; CHEMOTAXIS, LEUKOCYTE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC SURVEILLANCE; NEUROIMMUNOMODULATION; RECEPTORS, PATTERN RECOGNITION; TRAUMA, NERVOUS SYSTEM; WOUND HEALING;

EID: 84942524261     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.08.002     Document Type: Review

References (103)

1. Louveau A., et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015, 523:337-341.
2. Aspelund A., et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 2015, 212:991-999.
3. Bechmann I., et al. What is the blood-brain barrier (not)?. Trends Immunol. 2007, 28:5-11.
4. Ransohoff R.M., Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 2012, 12:623-635.
5. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239:290-292.
6. Nayak D., et al. In vivo dynamics of innate immune sentinels in the CNS. Intravital 2012, 1:95-106.
7. Kettenmann H., et al. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
8. Creagh E.M., O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 2006, 27:352-357.
9. Kigerl K.A., et al. Pattern recognition receptors and central nervous system repair. Exp. Neurol. 2014, 258:5-16.
10. Kato H., et al. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 2011, 243:91-98.
11. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 2005, 26:469-476.
12. Paul S., et al. Type I interferon response in the central nervous system. Biochimie 2007, 89:770-778.
13. van den Pol A.N., et al. Long-distance interferon signaling within the brain blocks virus spread. J. Virol. 2014, 88:3695-3704.
14. Nayak D., et al. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog. 2013, 9:e1003395.
15. Zhou S., et al. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol. 2010, 84:9452-9462.
16. Haller O., et al. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344:119-130.
17. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 2007, 81:1-5.
18. Guo H., et al. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 2015, 21:677-687.
19. Jamilloux Y., et al. Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection. Glia 2013, 61:539-549.
20. Hanamsagar R., et al. Critical role for the AIM2 inflammasome during acute CNS bacterial infection. J. Neurochem. 2014, 129:704-711.
21. Corps K.N., et al. Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol. 2015, 72:355-362.
22. Manson J., et al. Trauma alarmins as activators of damage-induced inflammation. Br. J. Surg. 2012, 99(Suppl. 1):12-20.
23. Ahmad A., et al. Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice. PLoS ONE 2013, 8:e57208.
24. Xiong Y., et al. Animal models of traumatic brain injury. Nat. Rev. Neurosci. 2013, 14:128-142.
25. Rosenberger K., et al. Intrathecal heat shock protein 60 mediates neurodegeneration and demyelination in the CNS through a TLR4- and MyD88-dependent pathway. Mol. Neurodegener. 2015, 10:5.
26. Junger W.G. Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 2011, 11:201-212.
27. Eltzschig H.K., et al. Purinergic signaling during inflammation. N. Engl. J. Med. 2012, 367:2322-2333.
28. Davalos D., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
29. Nimmerjahn A., et al. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
30. Kim J.V., Dustin M.L. Innate response to focal necrotic injury inside the blood-brain barrier. J. Immunol. 2006, 177:5269-5277.
31. Roth T.L., et al. Transcranial amelioration of inflammation and cell death after brain injury. Nature 2014, 505:223-228.
32. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 2007, 87:659-797.
33. Ulmann L., et al. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
34. de Rivero Vaccari J.P., et al. P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 2012, 32:3058-3066.
35. Wang X., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 2004, 10:821-827.
36. Kimbler D.E., et al. Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice. PLoS ONE 2012, 7:e41229.
37. Ankeny D.P., Popovich P.G. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Neuroscience 2009, 158:1112-1121.
38. Shechter R., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
39. Schwartz M., Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 2014, 33:7-22.
40. Brien J.D., et al. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 2008, 181:8568-8575.
41. + T cells in control of West Nile virus infection. J. Virol. 2004, 78:8312-8321.
42. McCandless E.E., et al. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11270-11275.
43. Cruz-Orengo L., et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208:327-339.
44. Kang S.S., et al. Migration of cytotoxic lymphocytes in cell cycle permits local MHC I-dependent control of division at sites of viral infection. J. Exp. Med. 2011, 208:747-759.
45. + T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 2009, 30:300-311.
46. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 2001, 19:65-91.
47. Kagi D., et al. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 1996, 14:207-232.
48. Phares T.W., et al. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J. Virol. 2012, 86:2416-2427.
49. Phares T.W., et al. IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis. J. Neuroimmunol. 2013, 263:43-54.
50. Phares T.W., et al. Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 2013, 5:732-752.
51. Lauterbach H., et al. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virol. J. 2007, 4:53.
52. + T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons. J. Virol. 2012, 86:8937-8948.
53. Swanson P.A., McGavern D.B. Viral diseases of the central nervous system. Curr. Opin. Virol. 2015, 11:44-54.
54. Kim J.V., et al. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191-195.
55. + T cell-mediated dendrite and synapse loss. J. Exp. Med. 2013, 210:2087-2103.
56. Herz J., et al. Therapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cells. J. Exp. Med. 2015, 212:1153-1169.
57. Nayak D., et al. Microglia development and function. Annu. Rev. Immunol. 2014, 32:367-402.
58. Greenhalgh A.D., David S. Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J. Neurosci. 2014, 34:6316-6322.
59. Rajbhandari L., et al. Toll-like receptor 4 deficiency impairs microglial phagocytosis of degenerating axons. Glia 2014, 62:1982-1991.
60. Boven L.A., et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006, 129:517-526.
61. Wang X., et al. Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris. Glia 2015, 63:635-651.
62. Kroner A., et al. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
63. Lampron A., et al. Inefficient clearance of myelin debris by microglia impairs remyelinating processes. J. Exp. Med. 2015, 212:481-495.
64. Gudi V., et al. Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned. Front. Cell. Neurosci. 2014, 8:73.
65. Hiremath M.M., et al. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 1998, 92:38-49.
66. Daws M.R., et al. Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur. J. Immunol. 2001, 31:783-791.
67. Daws M.R., et al. Pattern recognition by TREM-2: binding of anionic ligands. J. Immunol. 2003, 171:594-599.
68. Kawabori M., et al. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J. Neurosci. 2015, 35:3384-3396.
69. Poliani P.L., et al. TREM2 sustains microglial expansion during aging and response to demyelination. J. Clin. Invest. 2015, 125:2161-2170.
70. Wang Y., et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 2015, 160:1061-1071.
71. Vignali D.A., et al. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.
72. Lanteri M.C., et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 2009, 119:3266-3277.
73. + T cells and reduces chronic retroviral set points. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2420-2425.
74. Cervantes-Barragan L., et al. Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection. J. Immunol. 2012, 188:3678-3685.
75. Trandem K., et al. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J. Immunol. 2010, 184:4391-4400.
76. Truong P., McGavern D.B. A novel virus carrier state to evaluate immunotherapeutic regimens: regulatory T cells modulate the pathogenicity of antiviral memory cells. J. Immunol. 2008, 181:1161-1169.
77. Latchman Y.E., et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10691-10696.
78. Jin Y.H., et al. The role of interleukin-6 in the expression of PD-1 and PDL-1 on central nervous system cells following infection with Theiler's murine encephalomyelitis virus. J. Virol. 2013, 87:11538-11551.
79. + T lymphocytes through PD-L1. Glia 2014, 62:1582-1594.
80. Phares T.W., et al. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity. J. Immunol. 2009, 182:5430-5438.
81. Phares T.W., et al. Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J. Immunol. 2010, 185:5607-5618.
82. Shechter R., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
83. Trandem K., et al. Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice. J. Virol. 2011, 85:6822-6831.
84. Kulcsar K.A., et al. Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:16053-16058.
85. Puntambekar S.S., et al. Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination. Glia 2015, Published online June 30, 2015. 10.1002/glia.22880.
86. Hasko G., et al. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 2008, 7:759-770.
87. Ribeiro J.A., et al. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 2002, 68:377-392.
88. Paterniti I., et al. Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. J. Neuroinflamm. 2011, 8:31.
89. Dai S.S., et al. Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J. Neurosci. 2010, 30:5802-5810.
90. Wang N., et al. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front. Immunol. 2014, 5:614.
91. Hu X., et al. Microglial and macrophage polarization - new prospects for brain repair. Nat. Rev. Neurol. 2015, 11:56-64.
92. Kunis G., et al. IFN-gamma-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair. Brain 2013, 136:3427-3440.
93. Raposo C., et al. CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles. J. Neurosci. 2014, 34:10141-10155.
94. + T cells protect injured CNS neurons via IL-4. J. Clin. Invest. 2015, 125:699-714.
95. Kurschus F.C. T cell mediated pathogenesis in EAE: molecular mechanisms. Biomed. J. 2015, 38:183-193.
96. Wu G.F., et al. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J. Immunol. 2000, 165:2278-2286.
97. Franklin R.J. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
98. Carbajal K.S., et al. CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 2011, 59:1813-1821.
99. Carbajal K.S., et al. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11068-11073.
100. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
101. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
102. Cekanaviciute E., et al. Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice. Glia 2014, 62:1227-1240.
103. Göritz C., et al. A pericyte origin of spinal cord scar tissue. Science 2011, 333:238-242.